A path toward clinical trial diversity

Minority and marginalized communities have historically been underrepresented in local and federal governments and in dozens of private sectors globally. Pharma is no different; there exists a steep chasm that drugmakers have yet to bridge concerning research and trials. The longer this gulf exists, the harder it becomes to address – the feelings of mistrust,Read more …A path toward clinical trial diversity originally appeared inKevinMD.com.

Source: Kevin, M.D. - Medical Weblog - May 8, 2022 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/post-author/liz-beatty" rel="tag" data-wpel-link="internal" > Liz Beatty < /a > < /span > Tags: Conditions Medications Source Type: blogs